PDF(929 KB)
Cost‑utility analysis of sugemalimab plus chemotherapy as first‑line treatment for advanced gastric cancer
ZHAI Feng, LI Hongyang, WEI Qingqing, TU Qiubo, MAO Jianpeng
Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (6) : 698-703.
PDF(929 KB)
PDF(929 KB)
Cost‑utility analysis of sugemalimab plus chemotherapy as first‑line treatment for advanced gastric cancer
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
